1. Home
  2. CREG vs ALZN Comparison

CREG vs ALZN Comparison

Compare CREG & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CREG

Smart Powerr Corp.

HOLD

Current Price

$1.35

Market Cap

27.1M

Sector

Utilities

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$2.08

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CREG
ALZN
Founded
N/A
2016
Country
China
United States
Employees
N/A
N/A
Industry
Power Generation
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.1M
8.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CREG
ALZN
Price
$1.35
$2.08
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
71.6K
55.6K
Earning Date
02-14-2026
12-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$173,659.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$1.69
52 Week High
$14.70
$11.70

Technical Indicators

Market Signals
Indicator
CREG
ALZN
Relative Strength Index (RSI) 59.21 50.48
Support Level $1.23 $1.69
Resistance Level $1.39 $2.27
Average True Range (ATR) 0.13 0.13
MACD 0.04 0.00
Stochastic Oscillator 89.36 70.69

Price Performance

Historical Comparison
CREG
ALZN

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: